{
 "url": "https://etfiq.com/funds/bbc/holdings/",
 "section": "funds",
 "title": "BBC Holdings: All 131 Positions (Jul 31, 2026) | ETFIQ",
 "description": "All 131 BBC holdings with weights, as of Jul 31, 2026. The top 3 are TRAX 1.67%, MBX 1.24% and ATAI 1.23%. Download the full list as a CSV.",
 "as_of": "Jul 31, 2026",
 "ticker": "BBC",
 "fund": "Virtus Biotech Clinical Trials ETF",
 "fund_page": "https://etfiq.com/funds/bbc",
 "positions": 131,
 "positions_listed_on_page": 131,
 "lead": "BBC held 131 positions as of Jul 31, 2026. First Tracks Biotherapeutics Inc is the largest at 1.67%; the top 10 are 11.8% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/1559109/000094040026039005/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-07-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "First Tracks Biotherapeutics Inc",
   "ticker": "TRAX",
   "weight_pct": 1.673,
   "page": null
  },
  {
   "rank": 2,
   "holding": "MBX Biosciences Inc",
   "ticker": "MBX",
   "weight_pct": 1.244,
   "page": "https://etfiq.com/holdings/mbx/"
  },
  {
   "rank": 3,
   "holding": "AtaiBeckley Inc",
   "ticker": "ATAI",
   "weight_pct": 1.227,
   "page": null
  },
  {
   "rank": 4,
   "holding": "Monopar Therapeutics Inc",
   "ticker": "MNPR",
   "weight_pct": 1.214,
   "page": null
  },
  {
   "rank": 5,
   "holding": "Definium Therapeutics Inc",
   "ticker": "DFTX",
   "weight_pct": 1.178,
   "page": null
  },
  {
   "rank": 6,
   "holding": "Xencor Inc",
   "ticker": "XNCR",
   "weight_pct": 1.098,
   "page": "https://etfiq.com/holdings/xncr/"
  },
  {
   "rank": 7,
   "holding": "Zenas Biopharma Inc",
   "ticker": "ZBIO",
   "weight_pct": 1.064,
   "page": null
  },
  {
   "rank": 8,
   "holding": "Uniqure NV",
   "ticker": "QURE",
   "weight_pct": 1.06,
   "page": null
  },
  {
   "rank": 9,
   "holding": "Apogee Therapeutics Inc",
   "ticker": "APGE",
   "weight_pct": 1.017,
   "page": null
  },
  {
   "rank": 10,
   "holding": "Vor BioPharma Inc",
   "ticker": "VOR",
   "weight_pct": 0.987,
   "page": null
  },
  {
   "rank": 11,
   "holding": "REGENXBIO Inc",
   "ticker": "RGNX",
   "weight_pct": 0.975,
   "page": null
  },
  {
   "rank": 12,
   "holding": "LB Pharmaceuticals Inc",
   "ticker": "LBRX",
   "weight_pct": 0.945,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Damora Therapeutics Inc",
   "ticker": "DMRA",
   "weight_pct": 0.935,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Amylyx Pharmaceuticals Inc",
   "ticker": "AMLX",
   "weight_pct": 0.933,
   "page": null
  },
  {
   "rank": 15,
   "holding": "Dyne Therapeutics Inc",
   "ticker": "DYN",
   "weight_pct": 0.927,
   "page": "https://etfiq.com/holdings/dyn/"
  },
  {
   "rank": 16,
   "holding": "Oruka Therapeutics Inc",
   "ticker": "ORKA",
   "weight_pct": 0.925,
   "page": "https://etfiq.com/holdings/orka/"
  },
  {
   "rank": 17,
   "holding": "Nurix Therapeutics Inc",
   "ticker": "NRIX",
   "weight_pct": 0.917,
   "page": "https://etfiq.com/holdings/nrix/"
  },
  {
   "rank": 18,
   "holding": "ORIC Pharmaceuticals Inc",
   "ticker": "ORIC",
   "weight_pct": 0.897,
   "page": null
  },
  {
   "rank": 19,
   "holding": "GH Research PLC",
   "ticker": "GHRS",
   "weight_pct": 0.89,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Sionna Therapeutics Inc",
   "ticker": "SION",
   "weight_pct": 0.879,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Dianthus Therapeutics Inc",
   "ticker": "DNTH",
   "weight_pct": 0.873,
   "page": "https://etfiq.com/holdings/dnth/"
  },
  {
   "rank": 22,
   "holding": "Erasca Inc",
   "ticker": "ERAS",
   "weight_pct": 0.865,
   "page": "https://etfiq.com/holdings/eras/"
  },
  {
   "rank": 23,
   "holding": "Jade Biosciences Inc",
   "ticker": "JBIO",
   "weight_pct": 0.863,
   "page": null
  },
  {
   "rank": 24,
   "holding": "SELLAS Life Sciences Group Inc",
   "ticker": "SLS",
   "weight_pct": 0.856,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Palvella Therapeutics Inc",
   "ticker": "PVLA",
   "weight_pct": 0.856,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.157
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/bbc/holdings/bbc-holdings.csv",
 "json_book": "https://etfiq.com/data/books/bbc.json",
 "markdown": "https://etfiq.com/funds/bbc/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of BBC, data as of Jul 31, 2026. https://etfiq.com/funds/bbc/holdings/"
}